drugset / Trial / NCT05938374
Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma (SPARE-03)
Phase 2
Completed
52 enrolled
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing Jishuitan Hospital · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To investigate the safety and efficacy of preoperative moderately fractionated IMRT and concurrent Fluzoparib Hydrochloride for primary truncal or extremity soft tissue sarcoma.
Timeline
- Start
- 2023-05-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluzoparib | Small molecule | 100 mg | Oral |